chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 74.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Antibody test, Platelet count, Platelet count decreased, SARS-CoV-2 antibody test, White blood cell count
Clinical narrative: My platelet count was 44; This is a spontaneous report from a contactable consumer (patient). This 74-year-old male patient received dose 1 of BNT162B2 via an unspecified route of administration on 05Mar2021 at 16:00 (at the age of 74-years-old) as a single dose in the left arm for COVID-19 immunization. Medical history was none. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. Concomitant medications included atorvastatin calcium (LIPITOR) and losartan from unknown dates for unknown indications. The patient did not have any known allergies. In Mar2021, the patient did not have any adverse effects after vaccine but later in the week had routing blood work for cardiologist. The patient's platelet count was 44. The outcome of platelet count was 44 was not recovered. It was also reported that since the vaccination the patient had not been tested for COVID-19.   The lot number for BNT162B2 was not provided and will be requested during follow-up.
Age: 74.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Platelet count, Platelet count abnormal
Clinical narrative: My platelet count was 44; This is a spontaneous report from a contactable consumer (patient). This 74-year-old male patient received dose 1 of BNT162B2 via an unspecified route of administration on 05Mar2021 at 16:00 (at the age of 74-years-old) as a single dose in the left arm for COVID-19 immunization. Medical history was none. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. Concomitant medications included atorvastatin calcium (LIPITOR) and losartan from unknown dates for unknown indications. The patient did not have any known allergies. In Mar2021, the patient did not have any adverse effects after vaccine but later in the week had routing blood work for cardiologist. The patient's platelet count was 44. The outcome of platelet count was 44 was not recovered. It was also reported that since the vaccination the patient had not been tested for COVID-19.   The lot number for BNT162B2 was not provided and will be requested during follow-up.
Age: 74.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Platelet count, Platelet count decreased
Clinical narrative: My platelet count was 44; This is a spontaneous report from a contactable consumer (patient). This 74-year-old male patient received dose 1 of BNT162B2 via an unspecified route of administration on 05Mar2021 at 16:00 (at the age of 74-years-old) as a single dose in the left arm for COVID-19 immunization. Medical history was none. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. Concomitant medications included atorvastatin calcium (LIPITOR) and losartan from unknown dates for unknown indications. The patient did not have any known allergies. In Mar2021, the patient did not have any adverse effects after vaccine but later in the week had routing blood work for cardiologist. The patient's platelet count was 44. The outcome of platelet count was 44 was not recovered. It was also reported that since the vaccination the patient had not been tested for COVID-19.   The lot number for BNT162B2 was not provided and will be requested during follow-up.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Injection site pain, Musculoskeletal stiffness
Clinical narrative: burning feeling at location of injection started about 1 week after injection. Feels similar to initial injection. Not swollen or red.; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) via an unspecified route of administration in the arm left on 19Mar2021 at 13:45 (at the age of 52-year-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure (HBP). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not have any allergies to food, medications, or other products. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN), metoprolol (METROPROLOL) and colecalciferol (VITAMIN D3) for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Mar2021, the patient experienced burning feeling at location of injection started about 1 week after injection and it was not swollen or red. The patient felt similar to initial injection. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event burning feeling at location of injection was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vaccination site pain
Clinical narrative: burning feeling at location of injection started about 1 week after injection. Feels similar to initial injection. Not swollen or red.; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) via an unspecified route of administration in the arm left on 19Mar2021 at 13:45 (at the age of 52-year-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure (HBP). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not have any allergies to food, medications, or other products. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN), metoprolol (METROPROLOL) and colecalciferol (VITAMIN D3) for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Mar2021, the patient experienced burning feeling at location of injection started about 1 week after injection and it was not swollen or red. The patient felt similar to initial injection. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event burning feeling at location of injection was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain upper, Asthenia, Chills, Diarrhoea, Dizziness
Clinical narrative: injection site pain; headache; tiredness; chills; stomach pains; fever of 100.3; dizziness; weakness; This is spontaneous report received from a contactable consumer (patient) or other non HCP.  A 38-years-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: EP7533) via an unspecified route of administration, administered in Arm Left on 30Mar2021, at 15:30 (at the age of 38-years-old) as dose 1, single for COVID-19 immunization. Medical history included asthma, known allergies (Penicillin, Vincomycin, Levaquin, Wellbutrin, Anaphylaxis to Shellfish (Shrimp), Anaphylaxis to Shellfish, from an unknown date and unknown if ongoing. Concomitant medications two weeks included cetirizine hydrochloride (ZYRTEC ALLERGY); escitalopram oxalate (LEXAPRO); salbutamol sulfate (VENTOLIN CR) and montelukast all taken for an unspecified indication, start and stop date were not reported. No other vaccines in 4 weeks. The patient previously took vancomycin, Levaquin, wellbutrin and experienced drug hypersensitivity. No COVID prior to the vaccination. No COVID tested post vaccination. On 30Mar2021, 15:45, the patient experienced injection site pain, headache, tiredness, chills, stomach pain, fever of 100.3, dizziness and weakness. My main concern is extreme dizziness and weakness. Her side effects alleviated quickly. She had 9 days of severe, debilitating dizziness. The patient contacted her doctor and he wanted her to call Pfizer to see if she should get the second vaccine. patient did not had covid prior and post to vaccination. events resulted in patient visited Doctor or other healthcare professional office/clinic visit. The patient underwent lab tests and procedures which included body temperature: 100.3 on 30Mar2021. Therapeutic measures were taken as a result of adverse events and treatment with Meclizine was prescribed. The outcome of the events was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dry mouth, Fatigue, Headache, Injection site pain, Pain
Clinical narrative: injection site pain; headache; tiredness; chills; stomach pains; fever of 100.3; dizziness; weakness; This is spontaneous report received from a contactable consumer (patient) or other non HCP.  A 38-years-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: EP7533) via an unspecified route of administration, administered in Arm Left on 30Mar2021, at 15:30 (at the age of 38-years-old) as dose 1, single for COVID-19 immunization. Medical history included asthma, known allergies (Penicillin, Vincomycin, Levaquin, Wellbutrin, Anaphylaxis to Shellfish (Shrimp), Anaphylaxis to Shellfish, from an unknown date and unknown if ongoing. Concomitant medications two weeks included cetirizine hydrochloride (ZYRTEC ALLERGY); escitalopram oxalate (LEXAPRO); salbutamol sulfate (VENTOLIN CR) and montelukast all taken for an unspecified indication, start and stop date were not reported. No other vaccines in 4 weeks. The patient previously took vancomycin, Levaquin, wellbutrin and experienced drug hypersensitivity. No COVID prior to the vaccination. No COVID tested post vaccination. On 30Mar2021, 15:45, the patient experienced injection site pain, headache, tiredness, chills, stomach pain, fever of 100.3, dizziness and weakness. My main concern is extreme dizziness and weakness. Her side effects alleviated quickly. She had 9 days of severe, debilitating dizziness. The patient contacted her doctor and he wanted her to call Pfizer to see if she should get the second vaccine. patient did not had covid prior and post to vaccination. events resulted in patient visited Doctor or other healthcare professional office/clinic visit. The patient underwent lab tests and procedures which included body temperature: 100.3 on 30Mar2021. Therapeutic measures were taken as a result of adverse events and treatment with Meclizine was prescribed. The outcome of the events was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: injection site pain; headache; tiredness; chills; stomach pains; fever of 100.3; dizziness; weakness; This is spontaneous report received from a contactable consumer (patient) or other non HCP.  A 38-years-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: EP7533) via an unspecified route of administration, administered in Arm Left on 30Mar2021, at 15:30 (at the age of 38-years-old) as dose 1, single for COVID-19 immunization. Medical history included asthma, known allergies (Penicillin, Vincomycin, Levaquin, Wellbutrin, Anaphylaxis to Shellfish (Shrimp), Anaphylaxis to Shellfish, from an unknown date and unknown if ongoing. Concomitant medications two weeks included cetirizine hydrochloride (ZYRTEC ALLERGY); escitalopram oxalate (LEXAPRO); salbutamol sulfate (VENTOLIN CR) and montelukast all taken for an unspecified indication, start and stop date were not reported. No other vaccines in 4 weeks. The patient previously took vancomycin, Levaquin, wellbutrin and experienced drug hypersensitivity. No COVID prior to the vaccination. No COVID tested post vaccination. On 30Mar2021, 15:45, the patient experienced injection site pain, headache, tiredness, chills, stomach pain, fever of 100.3, dizziness and weakness. My main concern is extreme dizziness and weakness. Her side effects alleviated quickly. She had 9 days of severe, debilitating dizziness. The patient contacted her doctor and he wanted her to call Pfizer to see if she should get the second vaccine. patient did not had covid prior and post to vaccination. events resulted in patient visited Doctor or other healthcare professional office/clinic visit. The patient underwent lab tests and procedures which included body temperature: 100.3 on 30Mar2021. Therapeutic measures were taken as a result of adverse events and treatment with Meclizine was prescribed. The outcome of the events was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain upper, Asthenia, Body temperature, Chills, Dizziness
Clinical narrative: injection site pain; headache; tiredness; chills; stomach pains; fever of 100.3; dizziness; weakness; This is spontaneous report received from a contactable consumer (patient) or other non HCP.  A 38-years-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: EP7533) via an unspecified route of administration, administered in Arm Left on 30Mar2021, at 15:30 (at the age of 38-years-old) as dose 1, single for COVID-19 immunization. Medical history included asthma, known allergies (Penicillin, Vincomycin, Levaquin, Wellbutrin, Anaphylaxis to Shellfish (Shrimp), Anaphylaxis to Shellfish, from an unknown date and unknown if ongoing. Concomitant medications two weeks included cetirizine hydrochloride (ZYRTEC ALLERGY); escitalopram oxalate (LEXAPRO); salbutamol sulfate (VENTOLIN CR) and montelukast all taken for an unspecified indication, start and stop date were not reported. No other vaccines in 4 weeks. The patient previously took vancomycin, Levaquin, wellbutrin and experienced drug hypersensitivity. No COVID prior to the vaccination. No COVID tested post vaccination. On 30Mar2021, 15:45, the patient experienced injection site pain, headache, tiredness, chills, stomach pain, fever of 100.3, dizziness and weakness. My main concern is extreme dizziness and weakness. Her side effects alleviated quickly. She had 9 days of severe, debilitating dizziness. The patient contacted her doctor and he wanted her to call Pfizer to see if she should get the second vaccine. patient did not had covid prior and post to vaccination. events resulted in patient visited Doctor or other healthcare professional office/clinic visit. The patient underwent lab tests and procedures which included body temperature: 100.3 on 30Mar2021. Therapeutic measures were taken as a result of adverse events and treatment with Meclizine was prescribed. The outcome of the events was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Headache, Pyrexia, Vaccination site pain
Clinical narrative: injection site pain; headache; tiredness; chills; stomach pains; fever of 100.3; dizziness; weakness; This is spontaneous report received from a contactable consumer (patient) or other non HCP.  A 38-years-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: EP7533) via an unspecified route of administration, administered in Arm Left on 30Mar2021, at 15:30 (at the age of 38-years-old) as dose 1, single for COVID-19 immunization. Medical history included asthma, known allergies (Penicillin, Vincomycin, Levaquin, Wellbutrin, Anaphylaxis to Shellfish (Shrimp), Anaphylaxis to Shellfish, from an unknown date and unknown if ongoing. Concomitant medications two weeks included cetirizine hydrochloride (ZYRTEC ALLERGY); escitalopram oxalate (LEXAPRO); salbutamol sulfate (VENTOLIN CR) and montelukast all taken for an unspecified indication, start and stop date were not reported. No other vaccines in 4 weeks. The patient previously took vancomycin, Levaquin, wellbutrin and experienced drug hypersensitivity. No COVID prior to the vaccination. No COVID tested post vaccination. On 30Mar2021, 15:45, the patient experienced injection site pain, headache, tiredness, chills, stomach pain, fever of 100.3, dizziness and weakness. My main concern is extreme dizziness and weakness. Her side effects alleviated quickly. She had 9 days of severe, debilitating dizziness. The patient contacted her doctor and he wanted her to call Pfizer to see if she should get the second vaccine. patient did not had covid prior and post to vaccination. events resulted in patient visited Doctor or other healthcare professional office/clinic visit. The patient underwent lab tests and procedures which included body temperature: 100.3 on 30Mar2021. Therapeutic measures were taken as a result of adverse events and treatment with Meclizine was prescribed. The outcome of the events was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Incorrect route of product administration, Injected limb mobility decreased, X-ray
Clinical narrative: aggravated arthritic; had severe pain in the joint; They looked at it and thought it was administered too high; unable to raise my arm/ I couldn't move my arm anymore; The pain felt like having a rotator cuff surgery in my arm; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 78-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EN6207 and expiry date: unknown), dose 1 via an unspecified route of administration on 19Mar2021 as DOSE 1, SINGLE, dose 2 via an unspecified route of administration on 08Apr2021 (Batch/Lot Number: EW0151) as DOSE 2, SINGLE for covid-19 immunisation (age at vaccination: 78-years-old). The patient medical history was not reported. There were no concomitant medications. The patient experienced they looked at it and thought it was administered too high, unable to raise my arm/ I couldn't move my arm anymore, The pain felt like having a rotator cuff surgery in my arm, on 19Mar2021, aggravated arthritic, had severe pain in the joint on unknown date. The patient underwent lab tests and procedures which included weight: 220lbs-225lbs lbs on an unknown date (Caller states 220lbs-225lbs, somewhere in there). Therapeutic measures were taken as a result of unable to raise my arm/ i couldn't move my arm anymore, the pain felt like having a rotator cuff surgery in my arm (Caller is going through Physical therapy). Outcome of the events aggravated arthritic, The pain felt like having a rotator cuff surgery in my arm and had severe pain in the joint was unknown, unable to raise my arm/ I couldn't move my arm anymore was recovering.  Follow-up (22Apr2021): This is a follow-up spontaneous report from a contactable consumer which included Patient characteristics, Event, drug information.  No follow-up attempts are possible. No further information is expected.
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Arthritis, Mobility decreased, Pain in extremity, Product administered at inappropriate site
Clinical narrative: aggravated arthritic; had severe pain in the joint; They looked at it and thought it was administered too high; unable to raise my arm/ I couldn't move my arm anymore; The pain felt like having a rotator cuff surgery in my arm; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 78-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EN6207 and expiry date: unknown), dose 1 via an unspecified route of administration on 19Mar2021 as DOSE 1, SINGLE, dose 2 via an unspecified route of administration on 08Apr2021 (Batch/Lot Number: EW0151) as DOSE 2, SINGLE for covid-19 immunisation (age at vaccination: 78-years-old). The patient medical history was not reported. There were no concomitant medications. The patient experienced they looked at it and thought it was administered too high, unable to raise my arm/ I couldn't move my arm anymore, The pain felt like having a rotator cuff surgery in my arm, on 19Mar2021, aggravated arthritic, had severe pain in the joint on unknown date. The patient underwent lab tests and procedures which included weight: 220lbs-225lbs lbs on an unknown date (Caller states 220lbs-225lbs, somewhere in there). Therapeutic measures were taken as a result of unable to raise my arm/ i couldn't move my arm anymore, the pain felt like having a rotator cuff surgery in my arm (Caller is going through Physical therapy). Outcome of the events aggravated arthritic, The pain felt like having a rotator cuff surgery in my arm and had severe pain in the joint was unknown, unable to raise my arm/ I couldn't move my arm anymore was recovering.  Follow-up (22Apr2021): This is a follow-up spontaneous report from a contactable consumer which included Patient characteristics, Event, drug information.  No follow-up attempts are possible. No further information is expected.
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Weight
Clinical narrative: aggravated arthritic; had severe pain in the joint; They looked at it and thought it was administered too high; unable to raise my arm/ I couldn't move my arm anymore; The pain felt like having a rotator cuff surgery in my arm; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 78-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EN6207 and expiry date: unknown), dose 1 via an unspecified route of administration on 19Mar2021 as DOSE 1, SINGLE, dose 2 via an unspecified route of administration on 08Apr2021 (Batch/Lot Number: EW0151) as DOSE 2, SINGLE for covid-19 immunisation (age at vaccination: 78-years-old). The patient medical history was not reported. There were no concomitant medications. The patient experienced they looked at it and thought it was administered too high, unable to raise my arm/ I couldn't move my arm anymore, The pain felt like having a rotator cuff surgery in my arm, on 19Mar2021, aggravated arthritic, had severe pain in the joint on unknown date. The patient underwent lab tests and procedures which included weight: 220lbs-225lbs lbs on an unknown date (Caller states 220lbs-225lbs, somewhere in there). Therapeutic measures were taken as a result of unable to raise my arm/ i couldn't move my arm anymore, the pain felt like having a rotator cuff surgery in my arm (Caller is going through Physical therapy). Outcome of the events aggravated arthritic, The pain felt like having a rotator cuff surgery in my arm and had severe pain in the joint was unknown, unable to raise my arm/ I couldn't move my arm anymore was recovering.  Follow-up (22Apr2021): This is a follow-up spontaneous report from a contactable consumer which included Patient characteristics, Event, drug information.  No follow-up attempts are possible. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Body temperature, Chills, Fatigue, Malaise
Clinical narrative: Chills; Tiredness; Headache; Muscle pain; Nausea; Loss appetite; Joint pain; Feeling unwell; Extremly dry mouth; This is a spontaneous report from a contactable consumer (patient). A 34-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EL0140), via an unspecified route of administration, in right arm on 10Feb2021 18:00 (at the age of 34-years-old) as dose 1, single for COVID-19 immunization. The patient's medical history was not reported. Concomitant medications included paracetamol (TYLENOL) from 04Feb2021 and then from 06Feb2021. The patient experienced chills, tiredness, headache, muscle pain, nausea, loss of appetite, joint pain, feeling unwell and extremly dry mouth in Feb2021. Therapeutic measures were taken as a result of chills. The outcome of the events was unknown.  No follow-up attempts are needed. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Myalgia, Pyrexia
Clinical narrative: Chills; Tiredness; Headache; Muscle pain; Nausea; Loss appetite; Joint pain; Feeling unwell; Extremly dry mouth; This is a spontaneous report from a contactable consumer (patient). A 34-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EL0140), via an unspecified route of administration, in right arm on 10Feb2021 18:00 (at the age of 34-years-old) as dose 1, single for COVID-19 immunization. The patient's medical history was not reported. Concomitant medications included paracetamol (TYLENOL) from 04Feb2021 and then from 06Feb2021. The patient experienced chills, tiredness, headache, muscle pain, nausea, loss of appetite, joint pain, feeling unwell and extremly dry mouth in Feb2021. Therapeutic measures were taken as a result of chills. The outcome of the events was unknown.  No follow-up attempts are needed. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Chills, Decreased appetite, Dry mouth, Fatigue
Clinical narrative: Chills; Tiredness; Headache; Muscle pain; Nausea; Loss appetite; Joint pain; Feeling unwell; Extremly dry mouth; This is a spontaneous report from a contactable consumer (patient). A 34-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EL0140), via an unspecified route of administration, in right arm on 10Feb2021 18:00 (at the age of 34-years-old) as dose 1, single for COVID-19 immunization. The patient's medical history was not reported. Concomitant medications included paracetamol (TYLENOL) from 04Feb2021 and then from 06Feb2021. The patient experienced chills, tiredness, headache, muscle pain, nausea, loss of appetite, joint pain, feeling unwell and extremly dry mouth in Feb2021. Therapeutic measures were taken as a result of chills. The outcome of the events was unknown.  No follow-up attempts are needed. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Malaise, Myalgia, Nausea
Clinical narrative: Chills; Tiredness; Headache; Muscle pain; Nausea; Loss appetite; Joint pain; Feeling unwell; Extremly dry mouth; This is a spontaneous report from a contactable consumer (patient). A 34-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EL0140), via an unspecified route of administration, in right arm on 10Feb2021 18:00 (at the age of 34-years-old) as dose 1, single for COVID-19 immunization. The patient's medical history was not reported. Concomitant medications included paracetamol (TYLENOL) from 04Feb2021 and then from 06Feb2021. The patient experienced chills, tiredness, headache, muscle pain, nausea, loss of appetite, joint pain, feeling unwell and extremly dry mouth in Feb2021. Therapeutic measures were taken as a result of chills. The outcome of the events was unknown.  No follow-up attempts are needed. No further information is expected.
Age: 24.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Erythema, Hypoaesthesia, Pain in extremity
Clinical narrative: The toes with pain and numbness are more red than my other toes; feeling pain and numbness in the fifth toe on my right foot/pain and numbness in my second toe on my right foot; feeling pain and numbness in the fifth toe on my right foot/pain and numbness in my second toe on my right foot; There is also numbness, redness and tingling./the second toe on my right foot, beside my big toe, is also painful, red and tingling.; This is a spontaneous report from a contactable consumer (patient). A 24-years-old non-pregnant female patient BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: ER8734, Expiry date: unknown) via an unspecified route of administration as on 07Apr2021 (at the age of 24-year-old) dose 1, single for covid-19 immunization. Medical history included SLE (systemic lupus erythematosus). Patient had no known allergies. Patient was not pregnant. Concomitant medication (in two weeks) included hydroxychloroquine. Patient had not received any other vaccine in four weeks. Patient did not had any prior Covid-19 vaccination and was not tested to covid post vaccination. On 07Apr2021, around 4 to 5 hours after receiving shot she started feeling pain and numbness in the fifth toe on her right foot and her pinky toe on her right foot became painful. On 09Apr2021 morning, she started feeling the same pain and numbness in her second toe in her right foot. She stated that toes with pain and numbness are more red than her other toes. There was also numbness, redness and tingling. Patient had not received any treatment for the events reported. Outcome of all events was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 24.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Erythema, Hypoaesthesia, Pain in extremity, Paraesthesia
Clinical narrative: The toes with pain and numbness are more red than my other toes; feeling pain and numbness in the fifth toe on my right foot/pain and numbness in my second toe on my right foot; feeling pain and numbness in the fifth toe on my right foot/pain and numbness in my second toe on my right foot; There is also numbness, redness and tingling./the second toe on my right foot, beside my big toe, is also painful, red and tingling.; This is a spontaneous report from a contactable consumer (patient). A 24-years-old non-pregnant female patient BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: ER8734, Expiry date: unknown) via an unspecified route of administration as on 07Apr2021 (at the age of 24-year-old) dose 1, single for covid-19 immunization. Medical history included SLE (systemic lupus erythematosus). Patient had no known allergies. Patient was not pregnant. Concomitant medication (in two weeks) included hydroxychloroquine. Patient had not received any other vaccine in four weeks. Patient did not had any prior Covid-19 vaccination and was not tested to covid post vaccination. On 07Apr2021, around 4 to 5 hours after receiving shot she started feeling pain and numbness in the fifth toe on her right foot and her pinky toe on her right foot became painful. On 09Apr2021 morning, she started feeling the same pain and numbness in her second toe in her right foot. She stated that toes with pain and numbness are more red than her other toes. There was also numbness, redness and tingling. Patient had not received any treatment for the events reported. Outcome of all events was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Cerebral small vessel ischaemic disease, Exposure during pregnancy, Fall, Hypoaesthesia
Clinical narrative: On 4/2, patient (22 weeks pregnant) developed numbness and tingling down one leg.  Symptoms progressed and she was admitted for BLE paralysis 4/5.  MRI showing transverse myelitis.  Process continued despite maximal medical therapy.  4/12 intubated.  4/20 tracheostomy.  7/11 C section and then developed post-operative bleeding needing mass transfusion protocol.  8/11 family decided to withdraw care and patient expired.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Immunoglobulin therapy, Magnetic resonance imaging head abnormal, Magnetic resonance imaging spinal abnormal, Muscular weakness, White matter lesion
Clinical narrative: On 4/2, patient (22 weeks pregnant) developed numbness and tingling down one leg.  Symptoms progressed and she was admitted for BLE paralysis 4/5.  MRI showing transverse myelitis.  Process continued despite maximal medical therapy.  4/12 intubated.  4/20 tracheostomy.  7/11 C section and then developed post-operative bleeding needing mass transfusion protocol.  8/11 family decided to withdraw care and patient expired.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Caesarean section, Death, Diplegia, Endotracheal intubation, Exposure during pregnancy
Clinical narrative: On 4/2, patient (22 weeks pregnant) developed numbness and tingling down one leg.  Symptoms progressed and she was admitted for BLE paralysis 4/5.  MRI showing transverse myelitis.  Process continued despite maximal medical therapy.  4/12 intubated.  4/20 tracheostomy.  7/11 C section and then developed post-operative bleeding needing mass transfusion protocol.  8/11 family decided to withdraw care and patient expired.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia, Magnetic resonance imaging abnormal, Myelitis transverse, Paraesthesia, Post procedural haemorrhage
Clinical narrative: On 4/2, patient (22 weeks pregnant) developed numbness and tingling down one leg.  Symptoms progressed and she was admitted for BLE paralysis 4/5.  MRI showing transverse myelitis.  Process continued despite maximal medical therapy.  4/12 intubated.  4/20 tracheostomy.  7/11 C section and then developed post-operative bleeding needing mass transfusion protocol.  8/11 family decided to withdraw care and patient expired.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Tracheostomy
Clinical narrative: On 4/2, patient (22 weeks pregnant) developed numbness and tingling down one leg.  Symptoms progressed and she was admitted for BLE paralysis 4/5.  MRI showing transverse myelitis.  Process continued despite maximal medical therapy.  4/12 intubated.  4/20 tracheostomy.  7/11 C section and then developed post-operative bleeding needing mass transfusion protocol.  8/11 family decided to withdraw care and patient expired.
Age: 43.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chills, Fatigue, Lip disorder, Myalgia, Nausea
Clinical narrative: Sore arm; Nausea; Vomiting; High fever; Chills; Shaking; Night sweats; Severe fatigue; Muscle aches; Funny taste; Weird feeling lips; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 12Apr2021 at 23:00 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. The patient had no other relevant medical history and no known allergies to medications, food, or other products. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 22Mar2021 at 15:00 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 at 12:00, the patient experienced sore arm, nausea, vomiting, high fever, chills, shaking, night sweats, severe fatigue, muscle aches, funny taste, weird feeling lips. The clinical outcome of the events sore arm, nausea, vomiting, high fever, chills, shaking, night sweats, severe fatigue, muscle aches, funny taste, weird feeling lips was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 43.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Night sweats, Pyrexia, Taste disorder, Tremor, Vomiting
Clinical narrative: Sore arm; Nausea; Vomiting; High fever; Chills; Shaking; Night sweats; Severe fatigue; Muscle aches; Funny taste; Weird feeling lips; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 12Apr2021 at 23:00 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. The patient had no other relevant medical history and no known allergies to medications, food, or other products. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 22Mar2021 at 15:00 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 at 12:00, the patient experienced sore arm, nausea, vomiting, high fever, chills, shaking, night sweats, severe fatigue, muscle aches, funny taste, weird feeling lips. The clinical outcome of the events sore arm, nausea, vomiting, high fever, chills, shaking, night sweats, severe fatigue, muscle aches, funny taste, weird feeling lips was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 43.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chills, Dysgeusia, Fatigue, Feeling abnormal, Myalgia
Clinical narrative: Sore arm; Nausea; Vomiting; High fever; Chills; Shaking; Night sweats; Severe fatigue; Muscle aches; Funny taste; Weird feeling lips; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 12Apr2021 at 23:00 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. The patient had no other relevant medical history and no known allergies to medications, food, or other products. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 22Mar2021 at 15:00 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 at 12:00, the patient experienced sore arm, nausea, vomiting, high fever, chills, shaking, night sweats, severe fatigue, muscle aches, funny taste, weird feeling lips. The clinical outcome of the events sore arm, nausea, vomiting, high fever, chills, shaking, night sweats, severe fatigue, muscle aches, funny taste, weird feeling lips was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 43.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Nausea, Night sweats, Pain in extremity, Pyrexia, Tremor
Clinical narrative: Sore arm; Nausea; Vomiting; High fever; Chills; Shaking; Night sweats; Severe fatigue; Muscle aches; Funny taste; Weird feeling lips; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 12Apr2021 at 23:00 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. The patient had no other relevant medical history and no known allergies to medications, food, or other products. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 22Mar2021 at 15:00 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 at 12:00, the patient experienced sore arm, nausea, vomiting, high fever, chills, shaking, night sweats, severe fatigue, muscle aches, funny taste, weird feeling lips. The clinical outcome of the events sore arm, nausea, vomiting, high fever, chills, shaking, night sweats, severe fatigue, muscle aches, funny taste, weird feeling lips was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 43.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Vomiting
Clinical narrative: Sore arm; Nausea; Vomiting; High fever; Chills; Shaking; Night sweats; Severe fatigue; Muscle aches; Funny taste; Weird feeling lips; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 12Apr2021 at 23:00 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. The patient had no other relevant medical history and no known allergies to medications, food, or other products. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 22Mar2021 at 15:00 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 at 12:00, the patient experienced sore arm, nausea, vomiting, high fever, chills, shaking, night sweats, severe fatigue, muscle aches, funny taste, weird feeling lips. The clinical outcome of the events sore arm, nausea, vomiting, high fever, chills, shaking, night sweats, severe fatigue, muscle aches, funny taste, weird feeling lips was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Chest pain, Chills, Disturbance in attention, Headache
Clinical narrative: Strong headache with pain in left leg Tight chest pain; Pain in left leg; Tight chest pain; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm on 08Apr2021 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. The medical history included hipo thyroid. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications included levothyroxine sodium (SYNTHROID) for an unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 19Mar2021 at 09:00 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. On 08Apr2021 at 18:00, the patient experienced strong headache with pain in left leg and tight chest pain. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events strong headache with pain in left leg and tight chest pain was not resolved at the time of this report.    No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Loss of personal independence in daily activities, Migraine, Pyrexia, Sleep disorder
Clinical narrative: Strong headache with pain in left leg Tight chest pain; Pain in left leg; Tight chest pain; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm on 08Apr2021 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. The medical history included hipo thyroid. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications included levothyroxine sodium (SYNTHROID) for an unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 19Mar2021 at 09:00 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. On 08Apr2021 at 18:00, the patient experienced strong headache with pain in left leg and tight chest pain. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events strong headache with pain in left leg and tight chest pain was not resolved at the time of this report.    No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.